CDC-Authored Genomics and Precision Health Publications Database

---

Last data update: Jan 21, 2025. (Total: 6495 publications)

All Cancer Diabetes Economic Environmental Equity FHH HLBS ID Implementation ND PGx PI Rare RCH dataset

Filtered By: Select to fine-tune your search Year Journal

Records 1-6 (of 6 Records)

Query Trace: Arana J[original query]
Safety of the 9-Valent Human Papillomavirus Vaccine. Shimabukuro TT , Su JR , Marquez PL , Mba-Jonas A , Arana JE , Cano MV . Pediatrics 2019 144 (6)
Safety of bivalent human papillomavirus vaccine in the US vaccine adverse event reporting system (VAERS), 2009-2017. Suragh TA , Lewis P , Arana J , Mba-Jonas A , Li R , Stewart B , Shimabukuro TT , Cano M . Br J Clin Pharmacol 2018 84 (12) 2928-2932
Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine in the Vaccine Adverse Event Reporting System (VAERS), 2009-2015. Arana JE , Harrington T , Cano M , Lewis P , Mba-Jonas A , Rongxia L , Stewart B , Markowitz LE , Shimabukuro TT . Vaccine 2018 36 (13) 1781-1788
Reports of Postural Orthostatic Tachycardia Syndrome After Human Papillomavirus Vaccination in the Vaccine Adverse Event Reporting System. Arana J , Mba-Jonas A , Jankosky C , Lewis P , Moro PL , Shimabukuro TT , Cano M . J Adolesc Health 2017 61 (5) 577-582
Post-licensure surveillance of 13-valent pneumococcal conjugate vaccine (PCV13) in adults aged ⩾19years old in the United States, Vaccine Adverse Event Reporting System (VAERS), June 1, 2012-December 31, 2015. Haber P , Arana J , Pilishvili T , Lewis P , Moro PL , Cano M . Vaccine 2016 34 (50) 6330-6334
Postlicensure safety surveillance for high-dose trivalent inactivated influenza vaccine in the Vaccine Adverse Event Reporting System, 1 July 2010-31 December 2010. Moro PL , Arana J , Cano M , Menschik D , Yue X , Lewis P , Haber P , Martin D , Broder K . Clin Infect Dis 2012 54 (11) 1608-14